首页> Frontiers in medicine> Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.

Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.

导出 LinkOut

翻译打印收藏纠错

第一作者： Brendan,O'Kelly

第一单位： Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin, Ireland.

作者： Brendan,O'Kelly ^[1] ; Ronan,McLaughlin ^[2] ; Roseann,O'Doherty ^[3] ; Hailey,Carroll ^[2] ; Roisin,Murray ^[1] ; Rachel,Dilworth ^[4] ; Laura,Corkery ^[4] ; Aoife G,Cotter ^[5] ; Tara,McGinty ^[5] ; Eavan G,Muldoon ^[1] ; Walter,Cullen ^[6] ; Gordana,Avramovic ^[6] ; Gerard,Sheehan ^[1] ; Denise,Sadlier ^[4] ; Michaela,Higgins ^[2] ; Peter,O'Gorman ^[3] ; Peter,Doran ^[7] ; Rosanna,Inzitari ^[7] ; Sinead,Holden ^[7] ; Yvonne,O'Meara ^[4] ; Sean,Ennis ^[6] ; John S,Lambert ^[8]

作者单位： Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin, Ireland. ^[1] Oncology Department, Mater Misericordiae University Hospital, Dublin, Ireland. ^[2] Haematology Department, Mater Misericordiae University Hospital, Dublin, Ireland. ^[3] Nephrology Department, Mater Misericordiae University Hospital, Dublin, Ireland. ^[4] Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin, Ireland.;Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.;School of Medicine, University College Dublin, Dublin, Ireland. ^[5] School of Medicine, University College Dublin, Dublin, Ireland. ^[6] Clinical Research Centre, University College Dublin, Dublin, Ireland. ^[7] Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin, Ireland.;School of Medicine, University College Dublin, Dublin, Ireland. ^[8]

关键词 COVID-19 SARS-CoV-2 first wave high-risk hospital cohorts rapid antibody test seroprevalence SARS-CoV-2

DOI 10.3389/fmed.2021.642318

PMID 34513853

发布时间 2021-09-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Frontiers in medicine

2021年8卷

642318页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Frontiers in medicine

2021年8卷

642318页

检索历史清除

Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.

Frontiers in medicine

相似文献

同项目论文

Frontiers in medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.

Frontiers in medicine

相似文献

同项目论文

Frontiers in medicine

相关期刊

检索历史清除